title: Abnormal recruitment of extracellular matrix proteins by excess Notch3 ECD: a new pathomechanism in CADASIL.
abstract: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, or CADASIL, one of the most common inherited small vessel diseases of the brain, is characterized by a progressive loss of vascular smooth muscle cells and extracellular matrix accumulation. The disease is caused by highly stereotyped mutations within the extracellular domain of the NOTCH3 receptor (Notch3(ECD)) that result in an odd number of cysteine residues. While CADASIL-associated NOTCH3 mutations differentially affect NOTCH3 receptor function and activity, they all are associated with early accumulation of Notch3(ECD)-containing aggregates in small vessels. We still lack mechanistic explanation to link NOTCH3 mutations with small vessel pathology. Herein, we hypothesized that excess Notch3(ECD) could recruit and sequester functionally important proteins within small vessels of the brain. We performed biochemical, nano-liquid chromatography-tandem mass spectrometry and immunohistochemical analyses, using cerebral and arterial tissue derived from patients with CADASIL and mouse models of CADASIL that exhibit vascular lesions in the end- and early-stage of the disease, respectively. Biochemical fractionation of brain and artery samples demonstrated that mutant Notch3(ECD) accumulates in disulphide cross-linked detergent-insoluble aggregates in mice and patients with CADASIL. Further proteomic and immunohistochemical analyses identified two functionally important extracellular matrix proteins, tissue inhibitor of metalloproteinases 3 (TIMP3) and vitronectin (VTN) that are sequestered into Notch3(ECD)-containing aggregates. Using cultured cells, we show that increased levels or aggregation of Notch3 enhances the formation of Notch3(ECD)-TIMP3 complex, promoting TIMP3 recruitment and accumulation. In turn, TIMP3 promotes complex formation including NOTCH3 and VTN. In vivo, brain vessels from mice and patients with CADASIL exhibit elevated levels of both insoluble cross-linked and soluble TIMP3 species. Moreover, reverse zymography assays show a significant elevation of TIMP3 activity in the brain vessels from mice and patients with CADASIL. Collectively, our findings lend support to a Notch3(ECD) cascade hypothesis in CADASIL disease pathology, which posits that aggregation/accumulation of Notch3(ECD) in the brain vessels is a central event, promoting the abnormal recruitment of functionally important extracellular matrix proteins that may ultimately cause multifactorial toxicity. Specifically, our results suggest a dysregulation of TIMP3 activity, which could contribute to mutant Notch3(ECD) toxicity by impairing extracellular matrix homeostasis in small vessels.
authors: INSERM, U740, Paris, F-75010, France.
authors: Marie
authors: M
authors: Monet-Leprêtre
authors: Iman
authors: I
authors: Haddad
authors: Céline
authors: C
authors: Baron-Menguy
authors: Maï
authors: M
authors: Fouillot-Panchal
authors: Meriem
authors: M
authors: Riani
authors: Valérie
authors: V
authors: Domenga-Denier
authors: Claire
authors: C
authors: Dussaule
authors: Emmanuel
authors: E
authors: Cognat
authors: Joelle
authors: J
authors: Vinh
authors: Anne
authors: A
authors: Joutel
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000818:Animals; D046589:CADASIL / Q000175:diagnosis* / Q000235:genetics / Q000378:metabolism*; D002478:Cells, Cultured; D004195:Disease Models, Animal; D016326:Extracellular Matrix Proteins / Q000235:genetics / Q000378:metabolism*; D005260:Female; D006706:Homeostasis / Q000235:genetics; D006801:Humans; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D008875:Middle Aged; D021381:Protein Transport / Q000235:genetics; D000071656:Receptor, Notch3; D051880:Receptors, Notch / Q000235:genetics / Q000378:metabolism*; D019717:Tissue Inhibitor of Metalloproteinase-3 / Q000235:genetics / Q000378:metabolism*
chemical_list: D016326:Extracellular Matrix Proteins; C499374:NOTCH3 protein, human; D000071656:Receptor, Notch3; D051880:Receptors, Notch; C088390:TIMP3 protein, human; D019717:Tissue Inhibitor of Metalloproteinase-3
keywords: CADASIL; Notch3; cerebrovasculature; extracellular matrix proteins; protein aggregation
references: Lancet Neurol. 2009 Jul;8(7):643-53
references: 19539236
references: Semin Thromb Hemost. 2011 Jun;37(4):408-24
references: 21805447
references: Cardiovasc Res. 2006 Feb 15;69(3):562-73
references: 16405877
references: Acta Neuropathol. 2006 Sep;112(3):333-9
references: 16871402
references: Nat Med. 2003 Apr;9(4):407-15
references: 12652295
references: Acta Neuropathol. 1995;89(6):500-12
references: 7676806
references: Cell. 2009 Apr 17;137(2):216-33
references: 19379690
references: J Clin Invest. 2000 Mar;105(5):597-605
references: 10712431
references: Blood. 2010 Nov 25;116(22):4720-30
references: 20739660
references: Am J Pathol. 2003 Jan;162(1):329-42
references: 12507916
references: Brain. 2009 Apr;132(Pt 4):933-9
references: 19174371
references: Semin Cell Dev Biol. 2011 Jul;22(5):476-81
references: 21458579
references: Genes Dev. 2004 Nov 15;18(22):2730-5
references: 15545631
references: Brain. 2009 Jun;132(Pt 6):1601-12
references: 19293235
references: Cell. 2011 Jan 7;144(1):67-78
references: 21215370
references: J Clin Invest. 2010 Feb;120(2):433-45
references: 20071773
references: Arch Neurol. 2005 Jul;62(7):1091-4
references: 16009764
references: Hum Mol Genet. 2011 Aug 15;20(16):3256-65
references: 21628316
references: Nature. 1996 Oct 24;383(6602):707-10
references: 8878478
references: Circ Res. 2010 Oct 1;107(7):860-70
references: 20689064
references: Acta Neuropathol. 2003 Aug;106(2):107-11
references: 12756589
references: Hum Mol Genet. 2009 Aug 1;18(15):2761-7
references: 19417009
references: Anal Biochem. 2001 Sep 15;296(2):279-83
references: 11554724
references: Am J Hum Genet. 2004 Feb;74(2):338-47
references: 14714274
references: Cardiovasc Res. 2012 Jul 15;95(2):138-46
references: 22266753
references: Exp Cell Res. 2004 Oct 1;299(2):454-64
references: 15350543
references: Lancet Neurol. 2010 Jul;9(7):689-701
references: 20610345
references: Lancet. 1997 Nov 22;350(9090):1511-5
references: 9388399
references: Invest Ophthalmol Vis Sci. 2011 Aug 03;52(9):6117-23
references: 21282576
references: Br J Ophthalmol. 1998 Nov;82(11):1329-34
references: 9924344
references: Anal Chem. 2004 Jul 15;76(14):4193-201
references: 15253663
references: Hum Mol Genet. 2007 Apr 15;16(8):982-92
references: 17331978
references: Sci Signal. 2008 Jul 08;1(27):re6
references: 18612141
references: Brain Res. 2012 May 25;1456:64-71
references: 22503071
references: Nat Genet. 1994 Dec;8(4):352-6
references: 7894485
references: J Biol Chem. 2007 Mar 2;282(9):6887-98
references: 17202148
references: Lancet Neurol. 2007 Feb;6(2):149-61
references: 17239802
references: Proc Natl Acad Sci U S A. 2011 May 24;108(21):E128-35
references: 21555590
references: Brain Res. 2007 Feb 23;1134(1):1-11
references: 17196184
references: Lancet. 2001 Dec 15;358(9298):2049-51
references: 11755616